Literature DB >> 15018660

Impact of immunizations with porcine reproductive and respiratory syndrome virus on lymphoproliferative recall responses of CD8+ T cells.

Josep Bassaganya-Riera1, Brad J Thacker, Shan Yu, Erin Strait, Michael J Wannemuehler, Eileen L Thacker.   

Abstract

The objective of this study was to investigate the immune responses elicited by either a modified-live (MLV) or a killed virus (KV) porcine reproductive and respiratory syndrome virus (PRRSV) vaccine. Specifically, we investigated the effects of multiple vaccinations on antigen-specific cellular and antibody responses against PRRSV. Twelve sows were obtained from herds with either a history of repeated MLV or KV PRRSV vaccination and a non-vaccinated, PRRSV-negative herd. Within herd, sows were divided into three groups and vaccinated with MLV, KV, or injected with saline. On day 0, 27, and 38, recall responses of peripheral blood mononuclear cells (PBMC) to the parent strains of the vaccines (e.g., MLV-VR2332 or KV-ISUP) were examined. The concentrations of total PRRSV-specific and virus-neutralizing serum antibodies were determined by ELISA and serum neutralization assays. Following immunization, the antigen-specific proliferation of CD8alphabeta(+), CD4(+)CD8alphaalpha(+) T cells in the naive sows was greater than in sows repeatedly vaccinated with KV or MLV. This diminished lymphoproliferative responses of CD8alphabeta(+) and CD4(+)CD8alphaalpha(+) T cells could be partially overcome by heterologous immunization. However, B cell proliferation, PRRSV antibody concentrations and virus neutralizing antibody titers were not enhanced by heterologous immunization and only KV vaccination increased antibody levels in previously immunized (MLV or KV) sows.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15018660     DOI: 10.1089/088282404322875430

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  19 in total

Review 1.  Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects.

Authors:  Wasin Charerntantanakul
Journal:  World J Virol       Date:  2012-02-12

2.  Expression of PPAR γ in intestinal epithelial cells is dispensable for the prevention of colitis by dietary abscisic acid.

Authors:  Raquel Hontecillas; Josep Bassaganya-Riera
Journal:  ESPEN J       Date:  2012-10-01

3.  Porcine reproductive and respiratory syndrome virus induces interleukin-15 through the NF-κB signaling pathway.

Authors:  Yi Fu; Rong Quan; Hexiao Zhang; Jun Hou; Jun Tang; Wen-hai Feng
Journal:  J Virol       Date:  2012-05-09       Impact factor: 5.103

4.  Augmented immune responses in pigs immunized with an inactivated porcine reproductive and respiratory syndrome virus containing the deglycosylated glycoprotein 5 under field conditions.

Authors:  Jung-Ah Lee; Nak-Hyung Lee; Joong-Bok Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Sang-Won Lee
Journal:  Clin Exp Vaccine Res       Date:  2016-01-27

5.  Assessment of the efficacy of two novel DNA vaccine formulations against highly pathogenic Porcine Reproductive and Respiratory Syndrome Virus.

Authors:  Luping Du; Fengjiao Pang; Zhengyu Yu; Xiangwei Xu; Baochao Fan; Kehe Huang; Kongwang He; Bin Li
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

6.  Biodegradable nanoparticle-entrapped vaccine induces cross-protective immune response against a virulent heterologous respiratory viral infection in pigs.

Authors:  Varun Dwivedi; Cordelia Manickam; Basavaraj Binjawadagi; Dechamma Joyappa; Gourapura J Renukaradhya
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

7.  Construction and immunogenicity of a DNA vaccine coexpressing GP3 and GP5 of genotype-I porcine reproductive and respiratory syndrome virus.

Authors:  Jing-Qiang Ren; Wen-Chao Sun; Hui-Jun Lu; Shu-Bo Wen; Jie Jing; Fu-Long Yan; Hao Liu; Cun-Xia Liu; Peng-Peng Xiao; Xing Chen; Shou-Wen Du; Rui Du; Ning-Yi Jin
Journal:  BMC Vet Res       Date:  2014-06-10       Impact factor: 2.741

Review 8.  Improved Vaccine against PRRSV: Current Progress and Future Perspective.

Authors:  Yuchen Nan; Chunyan Wu; Guoqian Gu; Weiyao Sun; Yan-Jin Zhang; En-Min Zhou
Journal:  Front Microbiol       Date:  2017-08-28       Impact factor: 5.640

9.  Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs.

Authors:  Almudena Sánchez-Matamoros; Agustí Camprodon; Jaime Maldonado; Rafael Pedrazuela; Joel Miranda
Journal:  Porcine Health Manag       Date:  2019-04-25

10.  PLGA nanoparticle entrapped killed porcine reproductive and respiratory syndrome virus vaccine helps in viral clearance in pigs.

Authors:  Varun Dwivedi; Cordelia Manickam; Basavaraj Binjawadagi; Gourapura J Renukaradhya
Journal:  Vet Microbiol       Date:  2013-05-20       Impact factor: 3.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.